∿foldscout.

MODEL INTELLIGENCE / VERIFIED RESEARCH

RoseTTAFold3 (RF3)

RosettaCommons all-atom biomolecular structure prediction in Foundry.

Developer: Institute for Protein Design / RosettaCommons, University of Washington

Commercial OK
COMMERCIAL RIGHTSCommercial OK
COMMERCIAL FEENo license fee identified
COMPUTESingle Gpu
MODEL WEIGHTSAvailable

Overview

Developer
Institute for Protein Design / RosettaCommons, University of Washington
Category
structure and complex prediction
Commercial rights
Commercial OK
License fee
No license fee identified
Open weights
Yes
Last verified
2026-10-16
Added to FoldScout
2026-10-16

Capabilities

Foundry's RF3 biomolecular structure prediction model, including protein-containing complexes; it accepts structure/sequence inputs and predicts atomic coordinates and confidence signals. Outputs are computational predictions, not affinity measurements.

When to use it

Use RF3 to predict biomolecular complexes and independently assess candidate structures alongside Boltz or other methods. Predictions require uncertainty checks and experimental validation.

Compute

Compute classification: single-gpu. This is a planning estimate, not a throughput benchmark; check the linked model installation documents for exact requirements.

Commercial licensing

Commercial permission — Commercial OK

Foundry's root BSD-3-Clause LICENSE.md explicitly covers source code and referenced model checkpoints; commercial use is permitted with preservation of attribution and no endorsement. Review any separately sourced component or data.

License fee — No license fee identified

The official Foundry code and referenced checkpoints have no commercial license fee; infrastructure and outside dependencies may cost money.

Free downloads do not necessarily permit company use. Code, checkpoints, external dependencies and compute expenses require separate review.

Official references

From computational design to experimental evidence

Validate your designed binder.

Seq2Study connects AI-designed proteins and antibodies with expression, affinity, stability and developability testing.

Explore Seq2Study ↗